185 related articles for article (PubMed ID: 24386114)
1. Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.
Yin LT; Hao HX; Wang HL; Zhang JH; Meng XL; Yin GR
PLoS One; 2013; 8(12):e82765. PubMed ID: 24386114
[TBL] [Abstract][Full Text] [Related]
2. Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice.
Wang HL; Zhang TE; Yin LT; Pang M; Guan L; Liu HL; Zhang JH; Meng XL; Bai JZ; Zheng GP; Yin GR
PLoS One; 2014; 9(9):e108377. PubMed ID: 25255141
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection.
Wang HL; Pang M; Yin LT; Zhang JH; Meng XL; Yu BF; Guo R; Bai JZ; Zheng GP; Yin GR
Acta Trop; 2014 Sep; 137():58-66. PubMed ID: 24813415
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice.
Yin LT; Ren YJ; You YJ; Yang Y; Wang ZX; Wang HL
Parasite; 2023; 30():46. PubMed ID: 37921620
[TBL] [Abstract][Full Text] [Related]
5. Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase.
Liu Z; Yuan F; Yang Y; Yin L; Liu Y; Wang Y; Zheng K; Cao J
Vaccine; 2016 Feb; 34(7):989-94. PubMed ID: 26514423
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice.
Zhang TE; Yin LT; Li RH; Wang HL; Meng XL; Yin GR
Parasit Vectors; 2015 Jan; 8():15. PubMed ID: 25582167
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.
Wang HL; Wen LM; Pei YJ; Wang F; Yin LT; Bai JZ; Guo R; Wang CF; Yin GR
Parasite; 2016; 23():12. PubMed ID: 26984115
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.
Wang HL; Li YQ; Yin LT; Meng XL; Guo M; Zhang JH; Liu HL; Liu JJ; Yin GR
PLoS One; 2013; 8(8):e70884. PubMed ID: 23967128
[TBL] [Abstract][Full Text] [Related]
9. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.
Wang HL; Wang YJ; Pei YJ; Bai JZ; Yin LT; Guo R; Yin GR
Parasite; 2016; 23():4. PubMed ID: 26842927
[TBL] [Abstract][Full Text] [Related]
11. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.
Li XZ; Lv L; Zhang X; Anchang KY; Abdullahi AY; Tu L; Wang X; Xia L; Zhang XX; Feng W; Lu C; Li S; Yuan ZG
Infect Genet Evol; 2016 Nov; 45():447-453. PubMed ID: 27742446
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice.
Liu Z; Yin L; Li Y; Yuan F; Zhang X; Ma J; Liu H; Wang Y; Zheng K; Cao J
BMC Immunol; 2016 Oct; 17(1):37. PubMed ID: 27716047
[TBL] [Abstract][Full Text] [Related]
13. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
Meng M; He S; Zhao G; Bai Y; Zhou H; Cong H; Lu G; Zhao Q; Zhu XQ
Parasit Vectors; 2012 Nov; 5():273. PubMed ID: 23181694
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice.
Tao Q; Fang R; Zhang W; Wang Y; Cheng J; Li Y; Fang K; Khan MK; Hu M; Zhou Y; Zhao J
Parasitol Res; 2013 Aug; 112(8):2871-7. PubMed ID: 23749087
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
19. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection.
Lee SH; Kim AR; Lee DH; Rubino I; Choi HJ; Quan FS
PLoS One; 2017; 12(4):e0175644. PubMed ID: 28406951
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
